Skip to content

Working memory training in children with neuropsychiatric disorders and borderline intellectual functioning.

Working memory training in children with neuropsychiatric disorders and borderline intellectual functioning.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20558
Enrollment
100
Registered
2011-06-07
Start date
2011-09-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children with neuropsychiatric disorders and borderline intellectual functioning

Interventions

Cogmed© working memory training (Klingberg et al., 2005). Working memory training procedure: In a double blind randomized controlled trail, two groups, each containing 50 children, will be compared.

Sponsors

Karakter kinder- en jeugdpsychiatrie
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children aged between 10 years/0 months and 13 years/11 months, known in psychiatric health care and/or special education; 2. Neuropsychiatric disorders (ADHD, ASD, or a combination of those two, possibly in combination with comorbid ODD), classified by the DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 2000); 3. IQ score between 70 and 85 (BIF); 4. Access to a PC with Windows Vista or Windows XP with internet connection and speakers (at home or school).

Exclusion criteria

Exclusion criteria: 1. Currently intensive (i.e. weekly) individual or group psychotherapy; 2. Regular use of other medication (stimulants / neuroleptics). When medication is used for ADHD, this isn’t a exclusion criteria in case of ‘room for improvement’; 3. Diagnosis of one or more of the following comorbid psychiatric disorders: A. Major depression; B. Bipolar disorder; C. Psychotic disorder; D. Chronically motor tic disorder or Gilles de la Tourette; E. Conduct disorder; F. Eating disorders; G. Anxiety disorders. 4. Neurological disorders (e.g. epilepsy) in the recent two years; 5. Cardiovascular disease currently or in the past; 6. Serious motor and/or perceptual handicap; 7. Participation in another clinical trail simultaneously; 8. Insufficient motivation to follow the training; 9. Medical illness which needs medical treatment.

Design outcomes

Primary

MeasureTime frame
1. The measured difference in behavioral problems before and after training; 2. The measured difference in neurocognitive functioning before and after training; 3. The measured difference in schoolachievement before and after training. Study procedure from A-Z: In the following part, we will describe the whole study procedure from start to follow- up, including the rationale for the proposed measurements. In sum, there will be a selection phase, pre- and post-assessments and a follow-up. Note that an assessment in our “clinical care as usual” includes; 1. A clinical interview with the parents and the child (an intake); 2. A structural developmental interview; 3. A comprehensive set of questionnaires; 4. A neuropsychological assessment with an average duration of 2 – 2 ½ hours; 5. An appointment for instruction of the training; 6. An appointment for evaluation. So in sum, the post-assessment and the follow-up will be extra for the research project compared to our daily care as usual. To be comprehensive, below, we will describe the whole procedure. Part one: Selection phase. Scales and Questionnaires. An extensive clinical diagnostic procedure including a structural developmental interview and a clinical interview with the parents and the child, supervised by a child and adolescent psychiatrist will be scrutinized by a clinical diagnostic procedure including: 1. In case of ADHD and/or ASS, the ADHD and/or ASS criteria according to the DSM-IV will be checked and filled out by an experienced psychologist; 2. For assessment of other comorbid psychiatric disorders, the Diagnostic Interview Schedule for Children (DISC-IV), a highly structured diagnostic instrument designed for use by non-clinicians (Berument et.al., 1999) will be included; 3. The intellectual disabilities will also be checked before participation, through five subtests of the WISC-III-NL (Information, Vocabulary, Picture Completion, Block Design, Digit Span), (Kort et al., 2005). Part tw

Secondary

MeasureTime frame
Side effects (headache, extreme tiredness, sleepingproblems): A side effect checklist will be filled in (based on the Pittsburgh Side effects Ratingscale).

Contacts

Public ContactSammy L. Roording-Ragetlie

Karakter, cluster LVG Utrechtseweg 220

s.roording@karakter.com+31 (0)26 4002100

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)